Key facts
- This page summarizes James E. Ousley's Form 4 filing for Identiv, Inc. (INVE).
- 3 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 29 Oct 2021, 20:31.
James E. Ousley - 27 Oct 2021 Form 4 Insider Report for Identiv, Inc. (INVE)
- Reporting relationship
- Director
- Issuer ticker
- INVE
- Reported as of
- 27 Oct 2021
- Net transaction value
- -$311,803
- SEC form
- 4
- Accepted by SEC
- 29 Oct 2021, 20:31:48 UTC
- Prior SEC filing
- 05 Oct 2021
- Next SEC filing
- 03 Nov 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/ Ed Kirnbauer, Attorney in Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
James E. Ousley filed Form 4 for Identiv, Inc. (INVE) on 29 Oct 2021.
Change
- Previous filing in this sequence was filed on 05 Oct 2021.
- Current net transaction value: -$311,803.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
INVE
transaction
Common Stock
Sale
- Transaction value
- $102,397
- Shares
- -5,556
- Change %
- -2.1%
- Price
- $18.43
- Shares after
- 255,554
- Date
- 27 Oct 2021
- Ownership
- Direct
- Footnotes
- F1, F2, F3, F6
INVE
transaction
Common Stock
Sale
- Transaction value
- $104,119
- Shares
- -5,556
- Change %
- -2.2%
- Price
- $18.74
- Shares after
- 249,998
- Date
- 28 Oct 2021
- Ownership
- Direct
- Footnotes
- F1, F2, F4, F6
INVE
transaction
Common Stock
Sale
- Transaction value
- $105,286
- Shares
- -5,556
- Change %
- -2.2%
- Price
- $18.95
- Shares after
- 244,442
- Date
- 29 Oct 2021
- Ownership
- Direct
- Footnotes
- F1, F2, F5, F6
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 6 footnotes
Footnote F1
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2021.
Footnote F2
Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold.
Footnote F3
Represents a weighted average price. Actual sale prices ranged from $17.90 to $18.84.
Footnote F4
Represents a weighted average price. Actual sale prices ranged from $18.51 to $19.05.
Footnote F5
Represents a weighted average price. Actual sale prices ranged from $18.46 to $19.21.
Footnote F6
Includes an aggregate of 4,168 shares of common stock issuable pursuant to Restricted Stock Unit awards that have not vested.